Blair William & Co. IL Raises Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Blair William & Co. IL lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 35.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 145,121 shares of the company’s stock after purchasing an additional 37,611 shares during the quarter. Blair William & Co. IL’s holdings in GE HealthCare Technologies were worth $10,749,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bessemer Group Inc. grew its holdings in GE HealthCare Technologies by 24.3% during the first quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock worth $538,000 after acquiring an additional 1,306 shares during the period. Flagship Harbor Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 17.4% during the first quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company’s stock valued at $278,000 after acquiring an additional 511 shares during the last quarter. Lineweaver Wealth Advisors LLC purchased a new position in GE HealthCare Technologies during the second quarter worth about $592,000. Wealth Enhancement Advisory Services LLC lifted its position in GE HealthCare Technologies by 23.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company’s stock worth $4,105,000 after buying an additional 9,769 shares during the period. Finally, Farther Finance Advisors LLC lifted its position in GE HealthCare Technologies by 52.7% during the first quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company’s stock worth $357,000 after buying an additional 1,550 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on GEHC. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Weiss Ratings reiterated a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Citigroup lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their price target for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Finally, Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Six analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $85.78.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $71.01 on Friday. The stock has a 50 day moving average of $74.31 and a two-hundred day moving average of $72.28. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a market capitalization of $32.42 billion, a P/E ratio of 14.55, a P/E/G ratio of 2.71 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies’s revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the company earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.